Diet and nutrition in rheumatoid arthritis and other chronic inflammatory diseases

Journal of Clinical Biochemistry and Nutrition

Volumn 20, Issue 1, 1996, Pages 1-26

  Parke, Ann L ^a   Parke, Dennis V ^b   Jones, Francis Avery ^b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

antioxidants; food; inflammatory disease; reactive oxygen; rheumatoid arthritis

Indexed keywords

EID: 0029762912     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.20.1     Document Type: Review

References (135)

1. Darlington, L.G. (1991): Dietary therapy for arthritis. Rheum. Dis. Clinic, 17, 273-285.
2. Panush, R.S. (1991) Does food cause or cure arthritis? Rheum. Dis. Clinic, 17, 259-272
3. Meade, C.J., and Mertin, J. (1978): Fatty acids and immunity Adv. Lipid Res., 16, 127-165.
4. Kuehl, F.A., and Egan, R.W. (1980): Prostaglandins. arachidonic acid and inflammation. Science, 210, 978-984.
5. Dong, C.H., and Banks, J. (1973): The Arthritis Cookbook, Bantam, New York.
6. Dong, C.H., and Banks, J. (1975): New Hope for the Arthritic, Ballantine Publishers, New York.
7. Panush, R.S. (1991): Preface. Rheum. Dis. Clinic, 17, xiii-xiv.
8. Panush, R.S., Carter, R.L., and Katz, P. (1983): Diet therapy for rheumatoid arthritis. Arthritis Rheum.. 26, 462-471.
9. Ziff, M. (1983): Diet in the treatment of rheumatoid arthritis. Arthritis Rheum., 26, 457-461.
10. Coombs, R.R.A , and Gell, P.G.H. (1989): The classification of allergic reactions underlying disease, in Eicosanoids, Lipid Peroxidation and Cancer, ed. by Coombs, R.R.A., and Gell, P.G.H., Springer-Verlag, Berlin, pp. 143-151.
11. Parke, A.L., loannides, C., Lewis, D.F.V., and Parke, D.V. (1991): Molecular pathology of drug-disease interactions in chronic autoimmune inflammatory disease. Inflammopharmacology. 1, 3-36.
12. Uetrecht, J. (1990). Drug metabolism by leukocytes and its role in drug-induced lupus and other idiosyncratic reactions. CRC Crit. Rev. ToxicoL, 20, 213-235.
13. Cross, C.E., Halliwell, B., Borish, E.T., Pryor, W.A., Ames, B.N., Saul, R.L., McCord, J.M., and Harman, D. (1987): Oxygen radicals and human disease. Ann. Intern. Med., 107, 526-545.
14. Halliwell, B., and Gutteridge, J.M.C. (1989): Free Radicals in Biology and Medicine, Clarendon Press, Oxford.
15. Parke, D.V. (1991): Nutritional requirements for detoxication of environmental chemicals. Food Addit. Contam., 8, 381-396.
16. Parke, D.V. (1993). The importance of diet and nutrition in the detoxication of chemicals, in Food, Nutrition and Chemical Toxicity. ed. by Parke, D.V., loannides, C., and Walker, R, Smith-Gordon, London, pp. 1-15
17. Minotti, G., and Aust, S.D. (1989): The role of iron in oxygen radical mediated lipid peroxidation. Chem. Biol. Interact., 71, 1-19.
18. Eling, T.E., and Krauss, R.S. (1985): Arachidonic-acid dependent metabolism of chemical carcinogens and toxicants, in Arachidonic Acid Metabolism and Tumor Initiation, ed. by Marnett. L., Martinus Nijhoff Publishing, Boston, pp. 83-124.
19. Minotti, G. (1993): Sources and role of iron in lipid peroxidation. Chem. Res. Toxicol., 6, 134-146.
20. de Sousa, M., da Silva, B., and Donnor, M. (1982): Iron and the lymphomyeloid system: Rationale for considering iron a target for immunosurveillance, in Proteins of Iron Storage and Transport, ed. by Saltman, P., Elsevier, North Holland.
21. Blake, D.R., Morris, C.J., and Dabbagh, A.J. (1993): The persistence of synovial inflammation - a critical role for iron promoted oxidative injury, in Food, Nutrition and Chemical Toxicity. ed. by Parke, D.V., loanides, C., and Walker, R., Smith-Gordon, London, pp. 205-213.
22. 12, and folic acid deficiency, and erythematosis responsiveness. Ann. Rheum. Dis., 49, 93-98.
23. Winyard, P.G., Blake, D.R., Chirico, S., Gutteridge, J.M.C., and Lunec, J. (1987): Mechanism of exacerbation of rheumatoid synovitis by total dose infusion of iron dextran- In vivo demonstration of iron-promoted oxidant stress. Lancet, 1, 69-72.
24. Biemond, P., Swaak, A.J.G , van Eijk, H.G., and Koster, J.F. (1986): Intra-articular ferritinbound iron in rheumatoid arthritis. Arthritis Rheum., 29, 1187-1193.
25. Wien, E.M., and Van Campen, D.R. (1991): Mucus and iron absorption regulation in rats fed various levels of dietary iron. J. Nutr., 121, 92-100.
26. Fraga, C.G., Oteiza, P.I., Golub, M.S., Gershwin, M.E., and Keen, C.L. (1990): Effects of aluminium on brain lipid peroxidation. Toxicol. Lett., 51, 213-219.
27. Birchall, D. (1993): Silicon and the bioavailability of aluminium-nutritional aspects, in Food, Nutrition and Chemical Toxicity, ed. by Parke, D.V., Ioannides, C., and Walker, R., Smith-Gordon, London, pp. 215-226.
28. Liu, P.T., Symons, A.M., and Parke, D.V. (1991): Autoxidative injury with loss of cytochrome P-450 following acute exposure of rats to fasting and ether anaesthesia. Xenobiotica, 21, 205-215.
29. Liu, P.T., Symons, A.M., and Parke, D.V. (1993): The effects of fasting and ether anaesthesia on hepatic and renal function in surgical trauma, in Food, Nutrition and Chemical Toxicity, ed. by Parke, D.V., Ioannides, C., and Walker, R., Smith-Gordon, London, pp. 385-394.
30. Liu, P.T., Symons, A.M., Howarth, J.A., Boulter, P.S., and Parke, D.V. (1993): Studies in surgical trauma - oxidative stress in ischaemia-reperfusion of rat liver, Clin. Sci. Mol. Med., 86, 453-460.
31. Panush, R.S. (1990): Food-induced (allergic) arthritis: Clinical and serological studies. J. Rheumatol., 17, 291-294.
32. Bahna, S.L., and Kanuga, J. (1991): Food hypersensitivity. Rheum. Dis. Clinic. 17, 243-250.
33. Cunningham-Rundles, C. (1991): Dietary antigens and immunologic disease in humans. Rheum. Dis. Clinic, 17, 287-308.
34. Husby, S., Oxelius, V.A., and Teisner, B. (1985): Humoral immunity to dietary antigens in healthy adults. Occurrence, isotype and IgG subclass distribution of serum antibodies to protein antigens. Int. Arch. Allergy Appl. Immunol., 77, 416-422.
35. Montanaro, A., and Bardana, E.J. (1991): Dietary amino acid-induced systemic lupus erythematosus. Rheum. Dis. Clinic, 17, 323-332.
36. Inman, RD (1991): Antigens, the gastrointestinal tract, and arthritis. Rheum. Dis. Clinic, 17, 309-322.
37. Palmblad, J., Hafström, I., and Ringertz, B. (1991): Antirheumatic effects of fasting. Rheum. Dis. Clinic, 17, 351-362.
38. Skoldstam, L., and Magnusson, K.-E. (1991) Fasting, intestinal permeability and rheumatoid arthritis. Rheum. Dis. Clinic, 17, 363-372.
39. Kilbourne, E.M., Rigau-Perez, J.G., and Heath, C.W.J. (1983): Clinical epidemiology of toxic oil syndrome: Manifestations of a new illness. N. Engl. J. Med., 309, 1408-1414.
40. Posada, de la Paz M., Philen, R.M., Borda, I.A., Bernet, J.T., Jr., Gancedo, J.C.B., DuClos. P.J., and Kilbourne, E.M. (1991): Manufacturing processes at two French rapeseed oil companies: Possible relationships to toxic oil syndrome in Spain. Food Chem. Toxicol., 29, 797-803.
41. Kilbourne, E., Bernert, J.T.J., and Posada, de la Paz M. (1988): Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain. Am. J. Epidemiol., 127, 1210-1227.
42. Tabuenca, J.M. (1981): Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet, 2, 567-568
43. Pestana, A., and Munoz, E. (1982): Anilides and the Spanish toxic oil syndrome. Nature, 298, 608.
44. Maneta-Peyret, L., Picard, J.-P., Bezian, J.-H., and Cassagne, C. (1992): Fatty acids rendered immunogenic. Immunol. Lett., 31, 227-232.
45. Kaufman, L.D., and Seidman, R.J. (1991): L-Tryptophan-associated eosinophilia-myalgia syndrome. Perspective of a new illness. Rheum. Dis. Clinic, 17, 427-441.
46. Katz, J.D., Wakem, C.J., and Parke, A.L. (1990): L-Tryptophan-associated eosinophiliamyalgia syndrome. J. Rheumatol., 17, 1559-1561.
47. Mayeno, A.N., Lin, F., and Foote, C.S. (1990): Characterization of "Peak E" a novel amino acid with the eosinophilia-myalgia syndrome. Science, 250, 1707-1708.
48. Love, P.E., and Santoro, S.A. (1990): Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and non-SLE disorders. Ann. Intern. Med., 112, 682-698.
49. Elkon, K.B., Parnassa, A P., and Foster, C.L. (1985): Lupus autoantibodies target ribosomal P proteins, J. Exp. Med., 162, 459-471.
50. Manns. M.P., Griffin, K.J., Quattrochi, L.C., Sacher, M., Thaler, H., Tukey, R.H., and Johnson, E.F. (1990): Identification of cytochrome P4501A2 as a human autoantigen. Arch. Biochem. Biophys., 280, 229-232.
51. Gilliland, B.C. (1991): Drug-induced autoimmune and hematologic disorders. Immunol. Allergy Clinic, 11, 525-553.
52. Park, B.K., and Kitteringham, N.R. (1990): Drug-protein conjugation and its immunological consequences. Drug Metab. Rev., 22, 87-144.
53. Uetrecht, J. (1990): Drug metabolism by leukocytes and its role in drug-induced lupus and other idiosyncratic reactions. CRC Crit. Rev. Toxicol, 20, 213-235.
54. Sugimura, T. (1985): Carcinogenicity of mutagenic heterocyclic amines formed during the cooking process. Mutat. Res., 150, 33-41.
55. May, D.G., Black, C.M., Olsen. N.J., Csuka, M.E., Tanner. S.B., Bellino, L., Porter, J.A., Wilkinson, G.R., and Branch, R.A. (1990): Scleroderma is associated with differences in individual route of drug metabolism: A study with dapsone, debrisoquine, and mephenytoin. Clin, Pharmacol. Ther., 48, 285-295.
56. Kenna, J.G., Satoh, H., Christ, DD., and Pohl, L.R. (1988): Metabolic basis for drug hypersensitivity: Antibodies in sera from patients with halothane hepatitis recognises liver neoantigens that contain the trifluoroacetyl group derived from halothane. J. Pharmacol. Exp. Ther., 245, 1103-1109.
57. Dansette, P.M., Amar, C., Smith. C., Pons, C., and Mansuy, D. (1990): Oxidative activation of the thiophene ring by hepatic enzymes. Biochem. Pharmacol., 39, 911-918.
58. Yvon, M., Anglade, P., and Wal. J.-M. (1990): Identification of the binding sites of benzyl penicilloyl, the allergenic metabolite of penicillin, on the serum albumin molecule, FEBS Lett., 263, 237-240.
59. Smith, P.C., Benet, L Z., and Mconagh. A.F. (1990): Covalent binding of zomepirac glucuronide to proteins: Evidence for a Schiff base mechanism. Drug Metab. Dispos., 18, 639-644.
60. Hyneck, M.L., Smith, P.C., Munafo, A., Mconagh, A., and Benet, L.Z. (1988): Disposition and irreversible plasma protein binding of tolmetin in humans. Clin. Pharmacol. Exp. Therap., 44, 107-114.
61. Mühlebach, S., Wyss, P.A., and Bickel, M.H. (1991): The use of 2.4,5.2′,4′,5′-hexachlorobiphenyl (6-CB) as an unmetabolizable lipophilic model compound. Pharm. Toxicol., 69, 410-415.
62. Waithe, W.I., Michaud. M., Harper, P.A., Okey, A.B., and Anderson, A. (1991): The Ah receptor, P4501A1 mRNA induction, and aryl hydrocarbon hydroxylase in a human lymphoblastoid cell line. Biochem. Pharmacol., 41, 85-92.
63. Stohs, S.J. (1990): Oxidative stress induced by 2,3,7,8,-tetrachlorodibenzo-p-dioxin (TCDD). Free Radical Biol. Med., 9, 79-90.
64. Rifkind, A.B., Gannon, M., and Gross, S.S. (1990): Arachidonic acid metabolism by dioxininduced cytochrome P450: A new hypothesis on the role of P450 in dioxin toxicity. Biochem. Biophys. Res. Commun., 172, 1180-1188.
65. Neubert, R., Jacob-Müller. U, Helge, H., Stahlmann, R., and Neubert, D. (1991): Polyhalogenated dibenzo-p-dioxins and dibenzofurans and the immune system. 2. In vitro effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on lymphocytes of venous blood from man and non-human primate (Callithrix jacckus). Arch. Toxicol., 65, 213-219.
66. Dröge, W. (1993): Cysteine and glutathione deficiency in AIDS patients. A rationale for the treatment with N-acetyl-cysteine. Pharmacology. 46, 61-65.
67. Hersh, E.M., Reuben, J.M., Bogerd, H., Rosenblaum, M., Bielski, M., Mansell, P.W.A., Rios, A., Newell, G.R., and Sonnenfeld, G. (1983): Effects of the recreational agent isobutyl nitrite on human peripheral blood leucocytes and on in vitro interferon production. Cancer Res., 42, 1365-1371.
68. Sigell, L.T., Kapp, F.T., Fusaro, G.A., Nelson, E.D., and Falck, R.S. (1978): Popping and snorting volatile nitrites: A current fad for getting high. Am. J. Psychiatry, 135, 1216-1218.
69. Newell, G.R., Adams, S.C., Mansell, P.W.A., and Hersh. E.M. (1984): Toxicity, immunosuppressive effects and carcinogenic potential of volatile nitrites Possible relationship to Karposi's syndrome. Pharmacotherapy, 4, 284-291.
70. Meloche, B.A., and O'Brien, P.J. (1993): S-Nitrosyl glutathione-mediated hepatocyte toxicity, Xenobiotica, 23, 863-871.
71. Nebert, D.W., and Gonzalez, F.J. (1987): P450 genes. Structure, evolution and regulation. Annu. Rev. Biochem., 56, 945-993.
72. Gonzalez, F.J., and Nebert, D.W. (1990): Evolution of the P450 gene superfamily. Trends Genet., 6, 182-186.
73. Thomas, J.P., Maiorino, M., Ursini. F., and Girotti, A.W. (1990): Protective action of phospholipid hydroperoxide glutathione peroxidase against membrane-damaging lipid peroxidation. In situ reduction of phospholipid and cholesterol hydroperoxides. J. Biol. Chem., 265, 454-461.
74. Pessayre, D., Dolder. A., Artigou. J Y , Wandscheer. J.C., Descatoire. V., Degott, C., and Benhamou, J.P. (1979): Effect of fasting on metabolite-mediated hepatotoxicity in the rat. Gastroenterology, 77, 264-271.
75. Ekström, G., and Ingelmann-Sundberg, M. (1989): Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P450IIEI). Biochem. Pharmacol., 38, 1313-1319.
76. Hong. J., Pan, J., Gonzalez, F.J., Gelboin, H., and Yang, C.S. (1987): Induction of a specific cytochrome P-450 (P-450j) by fasting. Biochem. Biophys. Res. Commun., 142, 1077-1083.
77. Laganiere, S., and Yu, B.P. (1987): Anti-lipoperoxidation action of food restriction. Biochem. Biophys. Res. Commun., 145, 1185-1191.
78. 2: Modulation by dietary restriction. Mech. Ageing Der., 65, 17-33.
79. Price, V.F., and Jollow, D.J. (1989): Effects of sulphur amino acid-deficient diets on acetaminophen metabolism and hepatotoxicity in rats. Toxicol. Appl. Pharmacol., 101, 356-369
80. Sunde, R.A., Guzke, G.E., and Hoekstra, W.G. (1981): Effect of dietary methionine on the biopotency of selenite and selenomethionine in the rat. J. Nutr., 111, 76-86.
81. Pantuck, E.J., Weissma, C., Pantuck, C.B., and Lee, Y.J. (1989): Effects of parenteral amino acid nutritional regimens on conjugative drug metabolism. Anaesth. Anal., 69, 727-731.
82. Matsuura, T., Yamada, K., and Kawasaki. T. (1992): Antioxidant role of cellular reduced coenzyme Q homologs and α-tocopherol in free radical-induced injury of hepatocytes isolated from rats fed diets with different vitamin E contents. Biochim. Biophys. Acta, 1127, 277-283.
83. Ginter, E (1989): Ascorbic acid in cholesterol metabolism and in detoxication of xenobiotic substances: Problem of optimum vitamin C intake. Nutrition, 5, 369-374
84. Ramakrishna, Rao, D.N., Fischer, V., and Mason, R.P. (1990). Glutathione and ascorbate reduction of the acetaminophen radical formed by peroxidase. J. Biol. Chem., 265, 844-847
85. Neumann, C.M . and Zannoni, V.G. (1990): Ascorbic acid deficiency and UDP-glucuronyl transferase. Qualitative and quantitative differences Biochem. Pharmacol., 39, 1085-1093.
86. Kaiser, S.D., Di Mascio, P., Murphy, M.E., and Sies, H. (1990): Physical and chemical scavengers of singlet molecular oxygen by tocopherols. Arch. Biochem. Biophys., 277, 101-108.
87. Urano, S., Kitahara, M., Kalo, Y., Hasegawa, Y., and Matsuo, M. (1990): Membrane stabilizing effect of vitamin E: Existence of a hydrogen bond between α-tocopherol and phospholipids in bilayer liposomes. J. Nutr. Sci. Vitaminol., 36, 513-519.
88. Gisinger, C., Watanabe, J., and Colwell, A (1990): Vitamin E and platelet eicosanoids in diabetes mellitus. Prostagland. Leuk. Essent. Fatty Acids, 40, 169-176.
89. Meydani, S.N., Shapiro, AC., Meydani, M., and Blumberg, J.B (1992): Lung eicosanoid synthesis is affected by age, dietary fat and vitamin E. J. Nutr., 122, 1627-1633.
90. Reddanna, P., Krishna Rao, M., and Channa Reddy, C. (1985): Inhibition of 5-lipoxygenase by vitamin E. FEBS Lett., 193, 39-43.
91. Kay, M.M.B., Bosman, G.J.C.G.M., Shapiro, S.S., Bendich, A., and Bassel, P.S. (1986): Oxidation as a possible mechanism of cellular aging: Vitamin E deficiency causes premature aging and IgG binding to erythrocytes. Proc. Natl. Acad. Sci. U.S.A., 83, 2463-2468
92. Palozza, P., and Krinsky, N.I., (1992): β-Carotene and α-tocopherol are synergistic antioxidants. Arch. Biochem. Biophys., 297, 184-187.
93. Fontana, J.A., Mezu, A.B., Cooper, B.N., and Miranda, D. (1990): Retinol modulation of estradiol-stimulated growth and of protein synthesis and secretion in human breast carcinoma cells. Cancer Res., 50, 1997-2002.
94. Ioannides, C., Ayrton, A.D., Keele, A., Lewis. D.F.V., Flatt, PR., and Walker, R. (1990): Mechanism of the in vitro antimutagenic action of retinol. Mutagenesis, 5, 257-262.
95. 1-induced mutagenesis in S. typhimurium T A100 and TA98. Nutr. Cancer, 13, 243-253.
96. Hill, D.L., and Grubbs, C.J. (1992): Retinoids and cancer prevention. Annu. Rev. Nutr., 12, 161-181.
97. Yoshioka, A., Miyachi, Y, Imamura, S., and Niwa, Y. (1986): Anti-oxidant effects of retinoids on inflammatory skin diseases. Arch. Dermatol. Res., 278, 177-183.
98. Ross, A.C. (1992): Vitamin A status: Relationship to immunity and the antibody response. Proc. Soc. Exp. Biol. Med., 200, 303-320.
99. Parke, D.V. (1994): The role of nutrition in the prevention and treatment of degenerative disease. Saudi Med. J., 15, 17-25.
100. Yoo, J-S., Park, H.S., Ning, S.M., Lee. M.J., and Yang, C.S. (1990): Effects of thiamine deficiency on hepatic cytochrome P-450 and drug-metabolizing enzyme activities. Biochem. Pharmacol., 39, 519-525.
101. Schoene, N.W., Morris, V.C., and Levander, O.A. (1986): Altered arachidonic acid metabolism in platelets and aortas from selenium-deficient rats. Nutr. Res., 6, 75-83.
102. Issekutz, A.C., and Lopes, N. (1992): Effect of Ebselen on polymorphonuclear leukocyte adhesion to and migration through cytokine-activated vascular endothelium. Int. J. Immunopharmacol., 14, 1383-1390.
103. Xu, Z., and Bray, T.M. (1992): Effect of increased microsomal oxygen radicals on the function and stability of cytochrome P450 in dietary zinc deficient rats. J. Nutr. Biochem., 3, 326-332.
104. Hietanen, E., Bartsh, H., Bareziat, J.-C., Ahotupa, M., Camus, A.-M., Cabral, J.R.P., and Laitinen, M. (1990): Quantity and saturation degree of dietary fats as modulators of oxidative stress and chemically-induced liver tumours in rats. Int. J. Cancer, 46, 640-647.
105. Yanagi, S., Yamashita, M., Tsuyuki, M., Morimoto, J., Haga, S., and Imai, S. (1992): Milk cream does not enhance 2,7-dimethylbenz(u)anthracene-induced mammary carcinogenesis. Cancer Lett., 61, 141-145.
106. Pitkänen. O.M. (1992): Peroxidation of lipid emulsions: A hazard for the premature infant receiving parenteral nutrition. Free Radical Biol. Med., 13, 239-245.
107. Eling, T.E., and Krause, R.S. (1985): Arachidonic acid-dependent metabolism of chemical carcinogens and toxicants, in Arachidonic Acid and Tumor Initiation, ed. by Marnett, L., Martinas Nijhoff, Boston, pp. 83-124.
108. Terano, T., Salmon, J.A., Higgs, G.A., and Moncada, S. (1986): Eicosapentaenoic acid as a modulator of inflammation Effect on prostaglandin and leukotriene synthesis Biochem. Pharmacol., 35, 779-785.
109. Lee, T.H., Hoover, R.L., Williams, J.D., Sperling, R.I., Ravalese, J., Spur, B.W., Robinson, D.R., Corey, E J., Lewis, R.A , and Austen, K.F. (1985): Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N. Engl. J. Med., 312, 1217-1224.
110. Rainsford, K.D. (1992): Diet, eicosanoids and chemical toxicity, in Food, Nutrition and Chemical Toxicity, ed. by Parke, D.V., Ioannides, C., and Walker, R., Smith-Gordon, London, pp. 171-180.
111. Meydani, S.N. (1992): Modulation of cytokine production by dietary polyunsaturated fatty acids. Proc. Soc. Exp. Biol. Med., 200, 189-193.
112. Vance, D.E. (1990): Phosphatidylcholine metabolism: Masochistic enzymology, metabolic regulation and lipoprotein assembly. Biochem. Cell Biol, 68, 1151-1165.
113. Schrager, T.F., and Newberne, P.M. (1993): Lipids, lipotropes and malignancy: A review and introduction of new data, in Food, Nutrition and Chemical Toxicity, ed. by Parke, D. V., Ioannides, C., and Walker, R., Smith-Gordon, London, pp. 227-247.
114. Lombardi, B., Chandar, N., and Locker. J. (1991): Nutritional model of hepatocarcinogenesis. Rat fed choline-devoid diet. Dig. Dis. Sci., 36, 979-984.
115. Noguchi, M., Taniya, T., Koyasaki, N., Kumaki, T., Miyasaki, I., and Mizukami, Y. (1991): Effects of prostaglandin synthetase inhibitor indomethacin on tumorigenesis, tumor proliferation, cell kinetics, and receptor contents of 7,12-dimethylbenz(α)anthracene-induced mammary carcinoma in Sprague-Dawley rats fed a high or low-fat diet. Cancer Res., 51, 2683-2689.
116. Ghoshal, A.K., Rushmore, T.H., Bui-Calderon, P., Roberfroid, M., and Farber, E. (1990): Prevention, by free-radical scavenger, of pro-oxidant effects of choline deficiency. Free Radical Biol Med., 8, 3-7.
117. Björkhem, I., Eggertsen, G., and Andersson, U. (1991): On the mechanism of stimulation of cholesterol 7α-hydroxylase by dietary cholesterol. Biochim. Biophys. Acta, 1085, 329-335.
118. Anderson, J.W., and Tietyen-Clark, J. (1986): Dietary fibre: Hyperlipidaemia, hypertension and coronary heart disease. Am. J. Gastroenterol., 81, 907-919.
119. Robinson, D.R. (1991): Alleviation of autoimmune disease by dietary lipids containing omega-3 fatty acids. Rheum. Dis. Clinic, 17, 213-222.
120. Slivka, A., Kang, J., and Cohen. G. (1986): Hydroxyl radicals and the toxicity of oral iron. Biochem. Pharmacol., 35, 553-556.
121. Keen, C.L., German, B.J., Mareschi, J.-P., and Gershwin, M.E. (1991): Nutritional modulation of murine models of autoimmunity. Rheum. Dis. Clinic, 17, 223-234.
122. Sperling, R.I. (1991): Dietary omega-3 fatty acids' Effects on lipid mediators of inflammation and rheumatoid arthritis. Rheum. Dis. Clinic, 17, 373-389.
123. Kremer, J.M. (1991): Clinical studies of omega-3 fatty acid supplementation in patients who have rheumatoid arthritis. Rheum. Dis. Clinic, 17, 391-402.
124. Nielsen, G.L., Faavang, K.L., Thomsen, B.S., Teglbjaerg, K.L., Jensen, L.T., Hansen, T.M., Lervang, H.H., Schmidt, E.B.. Dyerberg, J., and Ernst, E. (1992): The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis A randomized, double blind trial. Eur. J. Clin. Invest., 22, 687-691.
125. Callegari, P.E., and Zurier, R.B. (1991): Botanical lipids: Potential role in modulation of immunologic responses and inflammatory reactions. Rheum. Dis. Clinic, 17, 415-425.
126. Jännti, J., Nikkari, T., Solakivi, T., Vapaatalo, H., and Isomäki, H. (1989): Evening primrose oil in rheumatoid arthritis. Changes in serum lipids and fatty acids. Ann. Rheum. Dis., 48, 124-127.
127. Lundberg, A.-C., Åkesson, A., and Åkesson, B. (1992): Dietary intake and nutritional status in patients with systemic sclerosis. Ann. Rheum. Dis., 51, 1143-1148.
128. Kappus, H., and Diplock, A.T. (1992): Tolerance and safety of vitamin E: A toxicological position report. Free Radical Biol. Med., 13, 55-74.
129. Parke, D.V., and Lewis, D.F.V. (1992): Safety aspects of food preservatives. Food Addit. Contam., 9, 562-577.
130. Noguchi, N., Yoshida, Y., Kaneda, H., Yamamoto, Y., and Niki, E. (1992): Action of ebselen as an antioxidant against lipid peroxidation. Biochem. Pharmacol, 44, 39-44.
131. Parnham, M.J., Leyck, S., Graf, E., Dowling, E.J., and Blake, D.R. (1991): The pharmacology of ebselen. Agents Actions, 32, 4-9.
132. Lieber, C.S. (1991): Hepatic, metabolic and toxic effects of ethanol: 1991 update. Alcoholism, 5, 573-592.
133. Morgan, S.L., Baggott, J.E., Vaughn, W.H., Young, P.K., Austin, J.V., Krumdieck, C.L., and Alarcon, G.S. (1990): The effect of folic acid supplementation on the toxicity of lowdose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum., 33, 9-18.
134. Diplock, A.T. (1993): Low dietary selenium and its relationship to human disease, in Food, Nutrition and Chemical Toxicity, ed. by Parke, D.V., loannides, C., and Walker, R., Smith-Gordon, London, pp. 395-402.
135. Tarp, V., Stengaard-Pedersen, K., Hansen, J.C., Thorling, E.B. (1992): Glutathione redox cycle enzymes and selenium in severe rheumatoid arthritis: Lack of antioxidative response to selenium supplementation in polymorphonuclear leucocytes. Ann. Rheum. Dis., 51, 1044-1049.